Adjuvant therapy for pancreatic cancer

Journal of the Pancreas

Volumn 15, Issue 2, 2014, Pages 87-90

  Goodman, Martin D ^a   Saif, Muhammad Wasif ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

Adjuvant; Chemotherapy; Pancreatic neoplasms

Indexed keywords

BIOLOGICAL MARKER; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; DOCETAXEL; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; MATRILYSIN;

ADJUVANT CHEMORADIOTHERAPY; ADJUVANT THERAPY; BILIARY TRACT CANCER; CANCER ADJUVANT THERAPY; CANCER SURGERY; CONFERENCE PAPER; HUMAN; PANCREAS CANCER; PHASE 2 CLINICAL TRIAL (TOPIC); SURVIVAL RATE; SYMPOSIUM;

EID: 84897893781     PISSN: 15908577     EISSN: None     Source Type: Journal    
DOI: 10.6092/1590-8577%2F2324     Document Type: Conference Paper

References (14)

1. American Cancer Society. Cancer Facts & Figures 2013. Atlanta, Ga: American Cancer Society; 2013.
2. Saif MW. Controversies in the adjuvant treatment of pancreatic adenocarcinoma. JOP. J Pancreas (Online) 2007; 8:545-52.
3. Kalser MH, Ellenberg SS. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 1985; 120:899-903.
4. Klinkenbijl JH, Jeekel J, Sahmoud T, van Pel R, Couvreur ML, Veenhof CH, et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 1999; 230:776-82.
5. Regine WF, Winter KA, Abrams RA, Safran H, Hoffman JP, Konski A, et al. Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial. JAMA. 2008 Mar 5; 299(9):1019-26. Erratum in: JAMA. 2008 Apr 23/30; 299(16):1902.
6. Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med. 2004 Mar 18; 350(12):1200-10.
7. Oettle H. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer. JAMA. 2007 Jan 17; 297:267-277.
8. Neoptolemos JP, Stocken DD, Bassi C, Ghaneh P, Cunningham D, Goldstein D, et al. Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. JAMA. 2010 Sep 8; 304(10):1073-81.
9. Uesaka K, Fukutomi A, Boku N, Kanemoto H et al. Randomized phase III trial of adjuvant chemotherapy with gemcitabine versus S-1 for patients with resected pancreatic cancer (JASPAC-01 study). J Clin Oncol 30: 2012 (suppl 34; abstr 145).
10. Cho M, Wang-Gillam A, Gao F, Linehan D, Hawkins WG, Suresh R, Fournier C, Picus J, Tan B. Adjuvant gemcitabine plus docetaxel followed by 5FU chemoradiation for patients with resected pancreaticobiliary cancers: A single institution phase II study. 2014 Gastrointestinal Cancers Symposium J Clin Oncol 32, 2014 (suppl 3; abstr 325)
11. Kumar A, Falk G, Stephans KL, Walsh M, Pelley RJ, Abdel- Wahab M; Adjuvant chemoradiation to improve survival compared to adjuvant chemotherapy in selected patients with pancreatic cancer. 2014 Gastrointestinal Cancers Symposium J Clin Oncol 32, 2014 (suppl 3; abstr 330)
12. Heestand GH, Murphy JD, Moughan J, Regine W, Luo J, Graber MS, Kunz PL, Fisher GA, Guha C, Lin B, Mowat RB, Gaur R, Buyyounouski MK, Chen Y, Chang DT, Koong A. A novel biomarker panel examining response to adjuvant pancreatic cancer therapy in RTOG 9704. J Clin Oncol 32, 2014 (suppl 3; abstr 176)
13. Liao W, Chien KL, Lin YL, et al. Adjuvant treatments for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis. The Lancet Oncology, Volume 14, Issue 11, Pages 1095 - 1103, October 2013
14. Ii M, Yamamoto H, Adachi Y, Maruyama Y, Shinomura Y. Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp Biol Med (Maywood). 2006 Jan;231(1):20-7.